First Time Loading...

EC Healthcare
HKEX:2138

Watchlist Manager
EC Healthcare Logo
EC Healthcare
HKEX:2138
Watchlist
Price: 1.4 HKD Market Closed
Updated: May 3, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

5.5B
+6%
Assets
Growth Rates:
1 Year
+13%
3 Years
+116%
5 Years
+178%
7 Years
+377%
10 Years
-
3.7B
+12%
Liabilities
Growth Rates:
1 Year
+23%
3 Years
+136%
5 Years
+215%
7 Years
+763%
10 Years
-
1.9B
-5%
Equity
Growth Rates:
1 Year
-1%
3 Years
+85%
5 Years
+126%
7 Years
+154%
10 Years
-

Balance Sheet Decomposition
EC Healthcare

5.5B
Assets
3.7B
Liabilities
5.5B
Assets
3.7B
Liabilities
Current Assets 1.4B
Cash & Short-Term Investments 726.8m
Receivables 244.1m
Other Current Assets 453.7m
Non-Current Assets 4.1B
Long-Term Investments 643.8m
PP&E 1.6B
Intangibles 1.4B
Other Non-Current Assets 452.3m
Current Liabilities 1.7B
Accounts Payable 70.1m
Other Current Liabilities 1.6B
Non-Current Liabilities 2B
Long-Term Debt 1.1B
Other Non-Current Liabilities 851.4m

Balance Sheet
EC Healthcare

Rotate your device to view
Balance Sheet
Currency: HKD
Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
75
120
355
201
295
367
520
931
870
710
Cash
75
120
0
0
0
0
0
0
0
0
Cash Equivalents
0
0
355
201
295
367
520
931
870
710
Short-Term Investments
57
37
604
658
892
600
112
8
4
17
Total Receivables
241
183
49
52
69
105
98
182
183
244
Accounts Receivables
241
183
32
52
69
105
79
179
155
212
Other Receivables
0
0
16
0
0
0
19
3
28
32
Inventory
10
14
18
19
31
52
60
40
101
87
Other Current Assets
42
36
44
68
122
281
262
254
357
367
Total Current Assets
426
390
1 069
998
1 409
1 405
1 052
1 415
1 516
1 425
PP&E Net
45
52
59
70
101
295
725
792
1 193
1 587
PP&E Gross
45
52
59
70
101
295
725
792
1 193
0
Accumulated Depreciation
36
50
68
95
128
168
396
658
1 012
0
Intangible Assets
1
0
1
36
87
89
115
512
692
662
Goodwill
1
2
3
37
95
99
155
477
709
744
Long-Term Investments
0
0
0
25
235
306
330
332
403
644
Other Long-Term Assets
11
23
23
33
56
153
177
263
347
452
Other Assets
1
2
3
37
95
99
155
477
709
744
Total Assets
483
N/A
468
-3%
1 156
+147%
1 199
+4%
1 983
+65%
2 347
+18%
2 555
+9%
3 790
+48%
4 861
+28%
5 513
+13%
Liabilities
Accounts Payable
2
4
5
6
9
22
36
47
75
70
Accrued Liabilities
0
0
0
0
0
0
34
0
0
0
Short-Term Debt
25
0
0
0
461
498
262
287
0
0
Current Portion of Long-Term Debt
0
0
0
0
2
6
161
207
319
400
Other Current Liabilities
468
455
416
394
567
599
577
776
970
1 205
Total Current Liabilities
494
459
421
401
1 040
1 125
1 069
1 317
1 363
1 676
Long-Term Debt
0
0
0
1
98
41
297
535
622
1 132
Deferred Income Tax
1
2
0
3
4
6
11
75
105
103
Minority Interest
1
1
0
11
17
124
167
362
469
516
Other Liabilities
5
4
3
5
4
9
9
233
419
232
Total Liabilities
499
N/A
464
-7%
424
-9%
421
-1%
1 162
+176%
1 305
+12%
1 553
+19%
2 522
+62%
2 979
+18%
3 659
+23%
Equity
Common Stock
0
0
703
706
715
720
724
1 133
1 983
0
Retained Earnings
16
4
28
73
107
322
278
136
101
1 854
Other Equity
0
0
0
0
1
0
1
0
2
0
Total Equity
16
N/A
4
N/A
731
+19 667%
778
+6%
821
+5%
1 042
+27%
1 003
-4%
1 269
+27%
1 881
+48%
1 854
-1%
Total Liabilities & Equity
483
N/A
468
-3%
1 156
+147%
1 199
+4%
1 983
+65%
2 347
+18%
2 555
+9%
3 790
+48%
4 861
+28%
5 513
+13%
Shares Outstanding
Common Shares Outstanding
735
735
980
981
983
985
985
1 071
1 178
1 185

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.